Arvinas reported early-stage data for its PROTAC program in healthy volunteers, hoping the results will eventually translate ...

Eli Lilly licenses Sangamo's BBB-penetrating AAV capsid for CNS disease with $18M upfront; deal includes option for 4 more ...

Camilla Sylvest has moved on from Novo Nordisk after 28 years with the Danish pharma, including more than seven years as EVP ...

The Senate on Thursday voted to confirm trained surgeon and former daytime TV host Mehmet Oz as the next CMS administrator, ...

F-star Therapeutics becomes private, independent company after separating from invoX, plans to continue bispecific antibody ...

Roche on Thursday shared early positive results for its Alzheimer’s candidate trontinemab, the latest round of data in its ...

Drugmakers have leverage and are getting 'a real negotiation' with the government over the prices of products selected under ...

HHS Secretary Robert F. Kennedy Jr. has been called to testify before the Senate HELP and House E&C Committees following ...

FDA rejects Aldeyra's dry eye drug reproxalap again, seeks more data. Company plans 2025 resubmission. AbbVie partnership ...

There were nine PIPEs in the first quarter of 2025, compared to 34 in the same quarter of last year, according to data shared ...

SHL Medical opens $220M SC factory, DHL acquires Cryopdp, AGC forms new division, new facilities for NBE, Siemens-Miko Ghana ...

What was once a promis­ing area of can­cer im­munother­a­py has had an­oth­er late-stage fail­ure. BeiGene said Thurs­day ...